Page last updated: 2024-08-24

baicalin and entecavir

baicalin has been researched along with entecavir in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Huang, H; Shi, X; Zhou, P; Zhou, W; Zhu, H1

Other Studies

2 other study(ies) available for baicalin and entecavir

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
    Toxicology and applied pharmacology, 2017, 05-15, Volume: 323

    Topics: Animals; Animals, Newborn; Antiviral Agents; Biomarkers; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Therapy, Combination; Ducks; Flavonoids; Guanine; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 4; Host-Pathogen Interactions; Humans; RNA, Viral; Time Factors; Transcription, Genetic; Transfection; Viral Load

2017